Synthesis and screening of 6-alkoxy purine analogs as cell type-selective apoptotic inducers in Jurkat cells.
dc.contributor.author | Lorente-Macías, Álvaro | |
dc.contributor.author | Iañez, Inmaculada | |
dc.contributor.author | Jiménez-López, M Carmen | |
dc.contributor.author | Benítez-Quesada, Manuel | |
dc.contributor.author | Torres-Rusillo, Sara | |
dc.contributor.author | Díaz-Mochón, Juan J | |
dc.contributor.author | Molina, Ignacio J | |
dc.contributor.author | Pineda de Las Infantas, María J | |
dc.date.accessioned | 2025-01-07T16:11:04Z | |
dc.date.available | 2025-01-07T16:11:04Z | |
dc.date.issued | 2021-06-15 | |
dc.description.abstract | Purines are ubiquitous structures in cell biology involved in a multitude of cellular processes, because of which substituted purines and analogs are considered excellent scaffolds in drug design. In this study, we explored the key structural features of a purine-based proapoptotic hit, 8-tert-butyl-9-phenyl-6-benzyloxy-9H-purine (1), by setting up a library of 6-alkoxy purines with the aim of elucidating the structural requirements that govern its biological activity and to study the cell selectivity of this chemotype. This was done by a phenotypic screening approach based on cell cycle analysis of a panel of six human cancer cell lines, including T cell leukemia Jurkat cells. From this study, two derivatives (12 and 13) were identified as Jurkat-selective proapoptotic compounds, displaying superior potency and cell selectivity than hit 1. | |
dc.identifier.doi | 10.1002/ardp.202100095 | |
dc.identifier.essn | 1521-4184 | |
dc.identifier.pmid | 34128249 | |
dc.identifier.unpaywallURL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ardp.202100095 | |
dc.identifier.uri | https://hdl.handle.net/10668/27669 | |
dc.issue.number | 10 | |
dc.journal.title | Archiv der Pharmazie | |
dc.journal.titleabbreviation | Arch Pharm (Weinheim) | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Virgen Macarena | |
dc.organization | SAS - Hospital Universitario Virgen de Valme | |
dc.page.number | e2100095 | |
dc.pubmedtype | Journal Article | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | anticancer drugs | |
dc.subject | apoptosis | |
dc.subject | leukemia | |
dc.subject | phenotypic screening | |
dc.subject | purine analogs | |
dc.subject.mesh | Antineoplastic Agents | |
dc.subject.mesh | Apoptosis | |
dc.subject.mesh | Cell Line, Tumor | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Jurkat Cells | |
dc.subject.mesh | Leukemia, T-Cell | |
dc.subject.mesh | Purines | |
dc.subject.mesh | Structure-Activity Relationship | |
dc.title | Synthesis and screening of 6-alkoxy purine analogs as cell type-selective apoptotic inducers in Jurkat cells. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 354 |